Until then, the precautionary principle suggests that tirzepatide formulations without B12 are the lower-risk option for people who want to continue compounded therapy
If you eat smaller meals, you put less food in your stomach at one time
Side effects are most common during the first several weeks of treatment and after dose increases, and they often improve as the body adapts, Duah says
Pennsylvanias Medicaid spending for GLP-1s like Ozempic, Wegovy, and Zepbound exploded to an estimated $1.3 billion last year from $233 million in 2022, the year before Medicaid started covering the drugs for obesity
Rosenfeldt MT, O'Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A et al